Form 4 holding
President and CEO, Director
Latigo Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 114,453
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- By Farzan 2026 Descendants' Trust f/b/o ZAF